Receptorium serotonini 2A
 |
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
|
| Receptorium serotonini 2A HTR2A |
|---|
| Chromosoma: 13p46.83 -46.9 |
| Obsessum a drogis his: |
| Haloperidolum, Loxapinum, Quetiapinum. |
Receptorium 5-HT2A est receptorium serotonini et familiae receptoriorum proteino G copulatorum (classis Gq/11) cum serotonino ligando endogeno[1]. 5-HT est abbreviatura 5-hydroxy-tryptamini, quod est serotoninum.
In mammaliis receptoria 5-HT2A imprimis in neocortice, ibi in stratis variis (I, III, IV), reperiuntur[2].
Diversa hallucigena effectus suos cum mutationibus cognitionis et morum perceptionis per receptorium 5-HT2A exercent[3].
Medicamentum pimavanserinum agonista inversa et antagonista receptorii 5-HT2A est[4].
Nexus interni
Notae[recensere | fontem recensere]
- ↑ T L'Estrade E, Hansen HD, Erlandsson M, Ohlsson TG, Knudsen GM, Herth MM (2018). "Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging". ACS Chem Neurosci
- ↑ López-Giménez J. F., Vilaró M. T., Palacios J. M., Mengod G. (Ian 2001). "Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3HMDL100,907 autoradiography and in situ hybridization studies"]. The Journal of comparative neurology 429 (4): 571-89
- ↑ López-Giménez J. F., González-Maeso J. (2018). "Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways". Current topics in behavioral neurosciences 36: 45-73
- ↑ Abbas A., Roth B. L. (Dec 2008). "Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders". Expert opinion on pharmacotherapy 9 (18): 3251-9